ZBP1 and neoplasm: Compared to WT controls, key proliferation-related pathways, including the G2/M checkpoint, E2F targets, and MYC targets, were significantly downregulated in Zbp1−/− tumor cells, indicating impaired cell cycle progression and proliferative capacity.